Latest News and Press Releases

- Novel, disease-modifying treatment option for Pulmonary Arterial Hypertension (PAH), an orphan indication with a significant unmet medical need Kiel, GERMANY, September 8, 2025 – tiakis Biotech AG...

Leading international experts to support clinical development of BellaSeno´s pioneering resorbable breast implantsPivotal clinical trial to be initiated shortly Leipzig, Germany / Brisbane,...

Funding combines equity investment and convertible loanFocus on best-in-class, clinical-stage peanut allergen neutralizing antibody Further potential for developing Mabylon’s discovery and...

European Medicines Agency recognizes potential of lead compound MP1032 in addressing a high unmet medical need in Duchenne Muscular Dystrophy (DMD)Designation is paving the way for safer long-term...

Funding supports market launch of platform for clinical and commercial applicationsCompany targets Euro 15 billion in silico trials market and ICU decision support Munich, Germany – July 2, 2025 --...

Heat-triggered release mechanism unequivocally confirmedFavorable safety profile with good tolerability Signs of encouraging clinical activity in heavily pre-treated patients including meaningful...

Berlin, Germany – June 17th, 2025 – Captain T Cell GmbH, a biotech company developing next-generation TCR-based cell therapies for patients with solid tumors, today announced that it has been selected...

-       Successful track record in the commercialization of biopharmaceutical products as well as strategic advisory in orphan diseases Kiel, Germany, May 21, 2025 – tiakis Biotech AG, a...

ODD granted for the treatment of soft tissue sarcomas (STS)Thermosome adds 4 patents to its growing patent estate Munich, Germany – May 12, 2025 – Thermosome, a drug development company focused on...

Dr. Rietiker has considerable experience in the life sciences industry, including leadership positions in global pharmaceutical and medical device companies, and has overseen multiple major company...